Functional, asset and risk analysis excludes diversified technology companies from captive software development comparables under cost-plus arrangemen...
Mobile-phone electronic evidence failed to establish customs undervaluation, while duty survived on non-authentic origin certificates without importer...
Automotive radio classification treats integrated infotainment features as supplementary, placing complete and qualifying unassembled units under the ...
Separate corporate personality prevents directors from being personally liable for company deposits without a guarantee or independent legal undertaki...
Cross-segment derivatives manipulation: integrated order patterns can support interim restraints, while director liability requires responsibility, co...
The interim facilitation measure for export clearance of drugs and pharmaceutical consignments is extended until 31 December 2026, subject to the previously prescribed conditions. After that date, export clearance must strictly comply with the applicable CDSCO Office Order. All other procedural requirements and conditions governing such export consignments remain unchanged. The extension takes effect immediately.
The interim facilitation measure for export clearance of drugs and pharmaceutical consignments is extended until 31 December 2026, subject to the previously prescribed conditions. After that date, export clearance must strictly comply with the applicable CDSCO Office Order. All other procedural requirements and conditions governing such export consignments remain unchanged. The extension takes effect immediately.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
TaxTMI 
of 4907 
